Welcome to Rostock Registration

Pre-meeting registration will open on November 15. th, 2017 and will close on March 7. th, 2018. To register, please send an e-mail to Direktion.Neuro...

0 downloads 44 Views 7MB Size
Welcome to Rostock

Registration

Dear colleagues,

Pre-meeting registration will open on November 15th, 2017 and will close on March 7th, 2018. To register, please send an e-mail to [email protected] uni-rostock.de with your full name and affiliation. Please mention “Registration for Parkinson 2018” in the email header and include a payment confirmation of the registration fee.

we cordially invite you to our scientific meeting „The many faces of Parkinson’s disease – motor and non-motor symptoms from prodromal to advanced disease stages” at the University of Rostock, Germany, on March 16th and 17th, 2018. In this meeting, a panel of reputable international experts will discuss the pathophysiology, diagnosis and therapy of non-motor symptoms in Parkinson’s disease, which are known to affect the majority of patients in the course of disease and often significantly contribute to disability and impaired quality of life. In a special session, we will specifically address deep brain stimulation and its effects on non-motor symptoms and brain plasticity. In addition, young investigators will present exciting new data from their research on non-motor symptoms in short DataBlitzes. This meeting has been endorsed by the Movement Disorder Society and will also incorporate the 2018 Scientific meeting of the MDS NMS-PD Study Group. We are looking forward to interesting talks, fruitful discussions and an inspiring meeting at the shores of the Baltic Sea in Rostock! Carsten Buhmann, MD

Matthias Löhle, MD

Department of Neurology

Department of Neurology

University of Hamburg

University of Rostock

Alexander Storch, MD Department of Neurology University of Rostock

Department of Neurology

Registration fee Pre-meeting registration (until March 5th, 2018 [extended deadline]): 150 € On-Site registration (opens March 16th, 2018 (07:30 AM) through March 17th, 2018 (10:00 AM): 200 € The organizers kindly ask all participants to use the early premeeting registration option. If you register on-site at the conference desk you are kindly asked to pay cash. To pay the registration fee, please use bank transfer to: Bank name: Hypo Vereinsbank Rostock Account Holder: Universitätsmedizin Rostock IBAN: DE66 2003 0000 0019 5515 15 BIC: HYVEDEMM300 Reference: Fonds 892352, Parkinson 2018 Due to administrative regulations of the organizing institution, there is no other payment option available. For further information, please visit our website at: https://ctnr.med.uni-rostock.de/parkinson2018-rostock/ For all questions, please contact us by e-mail ([email protected]).

Sponsors AbbVie GmbH, Gemany (4,000 €) Bayer Vital GmbH, Germany (1,000 €) Desitin Arzneimittel GmbH, Germany (2,500 €) Global Kinetics (GKC), Australia (5,000 €) Grünenthal GmbH, Germany (5,000 €) Licher MT GmbH, Germany (1,000 €) Medtronic Deutschland GmbH, Germany (7,500 €) UCB Pharma GmbH, Germany (5,000 €) Zambon GmbH, Germany (1,800 €)

The many faces of Parkinson’s disease – Motor and non-motor symptoms from prodromal to advanced disease stages The 2018 Scientific meeting of the MDS NMS PD Study Group

Meeting Venue: University of Rostock, Universitätsplatz 1 18055 Rostock, Germany Meeting Date: med.uni-rostock.de

March 16th - 17th, 2018

Friday, March 16, 2018

13:55

Keynote lecture: Escape from neurodegeneration: Importance of physical and cognitive activity for brain plasticity Gerd Kempermann, MD

14:40

Coffee and Posters

07:30 Registration 08:50

09:00

09:00 09:25

09:50 10:15

Welcome K. Ray Chaudhuri, MD, FRCP, DSc and Alexander Storch, MD SESSION 1: Non-motor symptoms in pre-motor disease Chair: Carsten Buhmann, MD NMS to define prodromal PD Daniela Berg, MD Neuropsychiatric and cognitive features in prodromal PD Anette Schrag, PhD, FRCP REM sleep behavioural disorder (RBD) Claudia Trenkwalder, MD Young Investigator DataBlitz: The RaSPar study – Rasagiline and Sleep in PD Wiebke Schrempf, MD

10:30

Coffee and Posters

11:00

SESSION 2: Early stage of PD Chair: Pablo Martinez-Martin, MD, PhD Epidemiology and natural history of NMS

11:00



SESSION 3: Advanced stage of PD Chair: Anthony Schapira, DSc, MD 15:00 Cognitive impairment and dementia Angelo Antonini, MD, PhD 15:25 Pain Michele Tinazzi, MD, PhD 15:50 Autonomic dysfunction in late stage PD Cristian Falup-Pecurariu, MD 16:15 Young Investigator DataBlitz: Asymmetry correlation of motor symptoms and PLMS in PD Theresa Spitzer

Lunch and Posters

13:15

CRC 1270 ELAINE supported session: DBS and adult neurogenesis Chairs: Ursula van Rienen, PhD and Alexander Storch, MD Individualised DBS: From motor to non-motor management Lars Timmermann, MD Young Investigator DataBlitz: DBS-induced cellular plasticity in the PD rat model Kathrin Badstübner, PhD

13:15

13:40

David Brooks, MD DSc FRCP FMedSci 09:10

15:00

16:30

Coffee and Posters

16:45

SESSION 4: Pathophysiology of non-motor symptoms Chair: Peter Jenner, BPharm, PhD, DSc Genetics and NMS: Prospects for therapeutic intervention Anthony Schapira, DSc, MD Animal models of NMS Peter Jenner, BPharm, PhD, DSc Dopaminergic and non-dopaminergic mechanisms

16:45

17:10 17:35

Carsten Buhmann, MD 12:15

SESSION 5: Biomarkers of non-motor symptoms

08:45

Per Borghammer, MD, PhD, DMSc 10:00 Early risk stratification for late motor and non-motor complications with imaging Matthias Löhle, MD 10:25 Young Investigator DataBlitz: Loss of pigmented dopamine neurons quantified with AV-1451 PET Allan Hansen, PhD 11:00

11:25

11:50

12:15

12:40 20:00

Dinner & Scientific Networking

Saturday, March 17, 2018 08:00

Parallel meetings: - MDS NMS-PD Study Group Member Assembly Moderator: K. Ray Chaudhuri, MD, FRCP, DSc - Trainee Subgroup Member meeting Moderator: Nataliya Titova, MD, PhD

Sonography of brain and brain nerves Uwe Walter, MD

13:05

SESSION 6: The future of PD treatment: Personalised medicine Pablo Martinez-Martin, MD, PhD PD – a complex disease with multiple syndromes K. Ray Chaudhuri, MD, FRCP, DSc Personalised medicine and Parkinson’s disease? Nataliya Titova, MD, PhD New drug targets for motor and non-motor symptoms in PD Fabrizio Stocchi, MD, PhD Tailored pharmacological treatment of motor and non-motor symptoms in advanced PD Per Odin, MD, PhD Young Investigator DataBlitz: Kinetics of non-motor fluctuations in advanced PD Christiana Franke, MD